
Provention Bio PRVB
Quarterly report 2022-Q3
added 05-16-2026
Provention Bio DSO Ratio 2011-2026 | PRVB
Annual DSO Ratio Provention Bio
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.2 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.2 | 19.2 | 19.2 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
29 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
559 | $ 1.63 | -1.52 % | $ 191 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
321 | $ 31.56 | -0.46 % | $ 2.1 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 55.88 | -0.89 % | $ 5.03 B | ||
|
Compugen Ltd.
CGEN
|
400 | $ 2.69 | -3.24 % | $ 251 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.14 | 0.16 % | $ 653 M | ||
|
Affimed N.V.
AFMD
|
31.4 | - | -34.95 % | $ 21.5 M | ||
|
Eton Pharmaceuticals
ETON
|
39.1 | $ 30.51 | -4.24 % | $ 821 M | ||
|
Celyad Oncology SA
CYAD
|
64.4 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
IMV
IMV
|
2.16 K | - | - | $ 13.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Hutchison China MediTech Limited
HCM
|
93.9 | $ 11.45 | 1.96 % | $ 9.83 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K | - | -4.36 % | $ 27 M | ||
|
Heron Therapeutics
HRTX
|
198 | $ 0.86 | -3.79 % | $ 143 M | ||
|
ImmuCell Corporation
ICCC
|
47.5 | $ 9.97 | 0.66 % | $ 90 M | ||
|
Anika Therapeutics
ANIK
|
76.5 | $ 14.77 | -0.91 % | $ 212 M | ||
|
Advaxis
ADXS
|
3.28 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
126 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.36 | - | $ 5.53 M |